Roberts, S. C., et al. “MHC–Correlated Odour Preferences in Humans and the Use of Oral Contraceptives”. Proceedings of the Royal Society B: Biological Sciences 275, no. 1652 (2008): 2715–22.

Rojas-Walsson, R., et al. “Diagnosis and Management of Post-Pill Amenorrhea”. Journal of Family Practice 13, no. 2 (1981): 165–69.

Stewart, M. E., et al. “Effect of Cyproterone Acetate-Ethinyl Estradiol Treatment on the Proportions of Linoleic and Sebaleic Acids in Various Skin Surface Lipid Classes”. Archives of Dermatological Research 278, no. 6 (1986): 481–85.

University of Pennsylvania School of Medicine. “Two Thirds of Women Interested in Stopping Their Periods but Unsure About Safety”. ScienceDaily. October 4, 2007.

Wang, J. G., et al. “The Complex Relationship Between Hypothalamic Amenorrhea and Polycystic Ovary Syndrome”. Journal of Clinical Endocrinology and Metabolism 93, no. 4 (2008): 1394–97.

Wedekind, C., et al. “Body Odour Preferences in Men and Women: Do They Aim for Specific MHC Combinations or Simply Heterozygosity?” Proceedings of the Royal Society B: Biological Sciences 264, no. 1387 (1997): 1471–79.

Wyatt, K. M., et al. “Efficacy of Vitamin B-6 in the Treatment of Premenstrual Syndrome: Systematic Review”. British Medical Journal 318, no. 7195 (1999): 1375–81.

4. Верните себе свои месячные

American College of Obstetricians and Gynecologists Committee on Adolescent Health Care. “Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign”. Committee Opinion No. 651. December 2015. https://www.acog.org/-/media/Committee – Opinions/Committee-on-Adolescent-Health-Care/co651.pdf?dmc=1&ts=20180626 T0442019822.

Bouchard, C., et al. “Use of Oral Contraceptive Pills and Vulvar Vestibulitis: A Case-Control Study”. American Journal of Epidemiology 156, no. 3 (2002): 254–61.

Goldstein, A. T., et al. “Polymorphisms of the Androgen Receptor Gene and Hormonal Contraceptive Induced Provoked Vestibulodynia”. Journal of Sexual Medicine 11, no. 11 (2014): 2764–71.

5. Азбука детоксикации от гормональных контрацептивов

Baum, J. K., et al. “Possible Association Between Benign Hepatomas and Oral Contraceptives”. Lancet 2, no. 7835 (1973): 926–29.

Blackwell. “Oral Contraceptive Pill May Prevent More than Pregnancy: Could Cause Long-Term Problems with Testosterone”. ScienceDaily.com. January 5, 2006.

https:// www.sciencedaily.com/releases/2006/01/060104232338.htm.

Bradlow, H. L., et al. “Multifunctional Aspects of the Action of Indole-3-Carbinol as an Antitumor Agent”. Annals of the New York Academy of Sciences 889 (1999): 204–13.

Bradlow, H. L., et al. “2-Hydroxyestrone: The ‘Good’ Estrogen”. Journal of Endocrinology 150 suppl. (1996): S259–65.

Dawling, S., et al. “Catechol-o-methyltransferase (COMT)-Mediated Metabolism of Catechol Estrogens: Comparison of Wild-Type and Variant COMT Isoforms”. Cancer Research 61, no. 18 (2001): 6716–22.

De Waal, E. J., et al. “Differential Effects of 2,3,7,8-Tetrachlorodibenzo-p-dioxin, Bis(tri-n butyltin) Oxide, and Cyclosporine on Thymus Histophysiology”. Critical Reviews in Toxicology 27, no. 4 (1997): 381–430.

Edmondson, H. A., et al. “Liver-Cell Adenomas Associated with Use of Oral Contraceptives”. New England Journal of Medicine 294, no. 9 (1976): 470–72.

Eramo, S., et al. “Estrogenicity of Bisphenol A Released from Sealants and Composites: A Review of the Literature”. Annali di Stomatologia 1, nos. 3–4 (2010): 14–21.

Etminan, M., et al. “Oral Contraceptives and the Risk of Gallbladder Disease: A Comparative Safety Study”. Canadian Medical Association Journal 183, no. 8 (2011): 899–904.

Fishman, W. H. “Beta-Glucuronidase in the Metabolic Conjugation of Estrogenic Hormones”. Federation Proceedings 6, no. 1, pt. 2 (1947): 251.

Fowke, J. H., et al. “Brassica Vegetable Consumption Shifts Estrogen Metabolism in Healthy Postmenopausal Women”. Cancer Epidemiology, Biomarkers and Prevention 9, no. 8 (2000): 773–79.

Hofmann, A. F. “The Continuing Importance of Bile Acids in Liver and Intestinal Disease”. Archives of Internal Medicine 159, no. 22 (1999): 2647–58.

Klatskin, G. “Hepatic Tumors: Possible Relationship to Use of Oral Contraceptives”. Gastroenterology 73, no. 2 (1977): 386–94.

Kuhl, H., et al. “The Effect of Sex Steroids and Hormonal Contraceptives upon Thymus and Spleen on Intact Female Rats”. Contraception 28, no. 6 (1983): 587–601.

Lord, R. S., et al. “Estrogen Metabolism and the Diet-Cancer Connection: Rationale for Assessing the Ratio of Urinary Hydroxylated Estrogen Metabolites”. Alternative Medicine Review 7, no. 2 (2002): 112–29.

Marciani, L., et al. “Effects of Various Food Ingredients on Gallbladder Emptying”. European Journal of Clinical Nutrition 67, no. 11 (2013): 1182–87.

McCann, S. E., et al. “Changes in 2-Hydroxyestrone and 16α-Hydroxyestrone Metabolism with Flaxseed Consumption: Modification by COMT and CYP1B1 Genotype”. Cancer Epidemiology, Biomarkers and Prevention 16, no. 2 (2007): 256–62.

Meissner, K. “Hemorrhage Caused by Ruptured Liver Cell Adenoma Following Long-Term Oral Contraceptives: A Case Report”. Hepatogastroenterology 45, no. 19 (1998): 224–25. Mueck, A. O., et al. “Estradiol Metabolism and Malignant Disease”. Maturitas 43, no. 1 (2002): 1–10.

Muti, P., et al. “Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16Alpha-Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women”. Epidemiology 11, no. 6 (2000): 635–40.

Nime, F., et al. “The Histology of Liver Tumors in Oral Contraceptive Users Observed During a National Survey by the American College of Surgeons Commission on Cancer”. Cancer 44, no. 4 (1979): 1481–89.

Nwachukwu, J. C., et al. “Resveratrol Modulates the Inflammatory Response Via an Estrogen Receptor-Signal Integration Network”. Elife 3 (2014): e02057.

Oredipe, O. A., et al. “Dietary Glucarate-Mediated Inhibition of Initiation of Diethyl-nitrosamine-Induced Hepatocarcinogenesis”. Toxicology 74, nos. 2–3 (1992): 209–22.

Panzer, C., et al. “Impact of Oral Contraceptives on Sex Hormone – Binding Globulin and Androgen Levels: A Retrospective Study in Women with Sexual Dysfunction”. Journal of Sexual Medicine 3, no. 1: 104–13.

Prigge, J. R., et al. “Hepatocyte DNA Replication in Growing Liver Requires Either Glutathione or a Single Allele of TXNRD1”. Free Radical Biology and Medicine 52, no. 4 (2012): 803–10.

Racine, A., et al. “Menopausal Hormone Therapy and Risk of Cholecystectomy: A Prospective Study Based on the French E3N Cohort”. Canadian Medical Association Journal 185, no. 7 (2013): 555–61.

Rafogianis, R., et al. “Estrogen Metabolism by Conjugation”. Journal of the National Cancer Institute Monographs 27 (2000): 113–24.